NDA for sovleplenib in China as Hutchmed looks to bring this new treatment to ITP patients
Commercial-stage biopharma company, Hutchmed, has good news for adults with primary immune thrombocytopenia (ITP).
Archives for January 11, 2024
Challenges in data management - from breaking data silos to data democratization
WNS supports the research and brand teams of more than 30 life sciences companies. The company believes its comprehensive pharma market research capabilities help clients in assimilating information from various data sources.